Lp(a) Clinical Trials: The Genetic Risk Factor Finally Being Treated
Lp(a) clinical trials in 2026: who qualifies, what siRNA and antisense drugs do, and why this is one of the most-active cardiovascular trial segments.
Lp(a) clinical trials in 2026: who qualifies, what siRNA and antisense drugs do, and why this is one of the most-active cardiovascular trial segments.